Yesterday, The Bowser Report issued a daily mover alert on Female Health Company (FHCO) and Repro Med Systems (REPR) , both of which fell more than 10 percent for the day.
After announcing a warning letter from the FDA last week, REPR is down 26%. Today’s move, while on no news, is likely related to the same news.
Last week’s guidance still stands: Currently, REPR still remains a 10, as the FDA audit hasn’t affected the company’s fundamentals (yet, if at all). With this news, treat REPR with a bit more speculation, but don’t write it off entirely if you don’t have a position. For those who enter a position or currently have a position, follow the Game Plan.
FHCO sold off today on slightly above average volume. The stock, before today’s selling, gained over 50% in the last month.
FHCO has a Bowser Rating of 11, and is still under $3 per share. For those who don’t have a position, you may want to consider entering one. However, keep in mind that FHCO is up 81% ($1) from its recommendation price of $1.24.
For those with positions, please continue to follow the Game Plan, selling half at the double and the remainder after the stock drops 25% from its most recent high (currently $2.70).
To learn more about The Bowser Report, visit https://thebowserreport.com